The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
暂无分享,去创建一个
[1] I. H. Boer. Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2014 .
[2] D. Nathan,et al. Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[3] L. Aiello. Diabetic Retinopathy and Other Ocular Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[4] J. Albers,et al. Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[5] I. D. de Boer. Kidney Disease and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study , 2013, Diabetes Care.
[6] R. Gubitosi-Klug. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Summary and Future Directions , 2013, Diabetes Care.
[7] L. Aiello,et al. Intensive Diabetes Therapy Reduces Ocular Surgeries in Patients with Type 1 Diabetes: twenty-eight year followup of the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC) , 2013 .
[8] R. Garrick. Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes , 2012 .
[9] D. Penson,et al. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. , 2011, The Journal of urology.
[10] J. Albers,et al. Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.
[11] B. Zinman,et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). , 2009, Archives of internal medicine.
[12] J. Albers,et al. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.
[13] David M Nathan,et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. , 2008, Archives of ophthalmology.
[14] N. White,et al. Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial , 2008, Diabetes Care.
[15] B. Zinman,et al. Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited , 2008, Diabetes.
[16] P. Cleary,et al. Long-term effect of diabetes and its treatment on cognitive function. , 2007, The New England journal of medicine.
[17] B. Zinman,et al. Long-term effect of diabetes and its treatment on cognitive function , 2007 .
[18] M. Fisher,et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) , 2007 .
[19] N. Abate,et al. Ethnicity, type 2 diabetes & migrant Asian Indians. , 2007, The Indian journal of medical research.
[20] C. Best,et al. The internal secretion of the pancreas. 1922. , 2007, The Indian journal of medical research.
[21] David M Nathan,et al. The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study , 2006, Diabetes.
[22] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[23] T. Deckert,et al. Prognosis of diabetics with diabetes onset before the age of thirtyone , 2005, Diabetologia.
[24] D. O'leary,et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. , 2003, The New England journal of medicine.
[25] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[26] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[27] S. Genuth,et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.
[28] W. Tamborlane,et al. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.
[29] J. Wylie-Rosett,et al. Implementation of Treatment Protocols in the Diabetes Control and Complications Trial , 1995, Diabetes Care.
[30] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[31] J. Assal,et al. [Long-term complications in diabetes mellitus]. , 1989, Acta medica portuguesa.
[32] S. Genuth,et al. Diabetes Control and Complications Trial (DCCT): Results of Feasibility Study. The DCCT Research Group , 1987, Diabetes Care.
[33] J. Roth,et al. Control of blood glucose and diabetic vascular disease. , 1977, The New England journal of medicine.
[34] C. Best. The internal secretion of the pancreas. , 1922, Canadian Medical Association journal.
[35] H. Dolger. Clinical evaluation of vascular damage in diabetes mellitus. , 1947, Journal of the American Medical Association.
[36] J. D. Boyd,et al. AVOIDANCE OF DEGENERATIVE LESIONS IN DIABETES MELLITUS , 1942 .
[37] J. M. Patterson. The Diabetic Life: Its Control by Diet and Insulin , 1936, The Indian Medical Gazette.
[38] J. M. Patterson. The Diabetic Life: Its Control by Diet and Insulin , 1926, The Indian Medical Gazette.